Department Of Administration Doa #PT5057

Feasibility Study for Cell and Gene Therapy Ecosystem in Minnesota

Minnesota Rare Disease Advisory Council is requesting proposals for a feasibility study focused on cell and gene therapy (CGT) in Minnesota. - Government Buyer: - Minnesota Rare Disease Advisory Council - Scope of Work: - Conduct a comprehensive assessment of Minnesota's CGT research, innovation, commercialization, and manufacturing ecosystem - Identify strategic gaps and opportunities in the state's CGT landscape - Evaluate investment models used by leading states in CGT - Develop actionable recommendations to position Minnesota as a national leader in CGT development and commercialization - Products/Services Requested: - Feasibility study (1 unit) - Notable Requirements: - Cost proposal must not exceed $40,000 - Study must deliver a thorough analysis and practical recommendations - OEMs and Vendors: - No specific OEMs or vendors are mentioned - Estimated Contract Value: - Up to $40,000

Description

The Minnesota Rare Disease Advisory Council is requesting proposals for a feasibility study on Minnesota’s current capacity for rare disease cell and gene therapy (CGT). The study will assess the state's CGT research, innovation, commercialization, and manufacturing ecosystem. It will identify strategic gaps and opportunities, evaluate investment models used by leading states, and develop recommendations to position Minnesota as a national leader in CGT development and commercialization. The cost proposal for this project should not exceed $40,000.

View original listing